πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 423 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11220575

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11141465

Method of making a water-soluble polymer-factor VIII moiety conjugate

Nektar Therapeutics Β· Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11129794

Chemically modified small molecules

Nektar Therapeutics Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11111335

Method of preparing carboxylic acid functionalized polymers

Nektar Therapeutics Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11111214

Kappa opioid agonists and uses thereof

Nektar Therapeutics Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11091525

Method of refolding an interleukin-2 (IL-2) protein

Nektar Therapeutics Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11033631

Methods of treating CYP2D6 alternative metabolizers

Nektar Therapeutics Β· Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11007270

Polymer-semaxanib moiety conjugates

Nektar Therapeutics Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10960079

Conjugates of an IL-2 moiety and a polymer

Nektar Therapeutics Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10945972

Particulate materials

Nektar Therapeutics Β· Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10941248

Methods for preparing functionalized polymers from polymer alcohols

Nektar Therapeutics Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894087

Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds

Nektar Therapeutics Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10881738

Oligomer-beta blocker conjugates

Nektar Therapeutics Β· Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10869933

Oligomer-phenothiazine conjugates

Nektar Therapeutics Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10865186

Opioid agonists and uses thereof

Nektar Therapeutics Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10844076

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

Nektar Therapeutics Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10806794

Protease inhibitors having enhanced features

Nektar Therapeutics Β· Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10798955

Compositions of particulate coformulation

Nektar Therapeutics Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10786552

Il-2RΞ²-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 anti

Nektar Therapeutics Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10774181

N-maleimidyl polymer derivatives

Nektar Therapeutics Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10766864

Morphinan derivatives for the treatment of neuropathic pain

Nektar Therapeutics Β· Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10759906

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10736969

Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

Nektar Therapeutics Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10695435

Composition comprising a polymeric reagent

Nektar Therapeutics Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted